32.88
0.03 (0.09%)
| Previous Close | 32.85 |
| Open | 32.46 |
| Volume | 324,146 |
| Avg. Volume (3M) | 263,587 |
| Market Cap | 1,198,124,160 |
| Price / Earnings (Forward) | 9.97 |
| Price / Sales | 0.800 |
| Price / Book | 5.81 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 |
| Profit Margin | -30.60% |
| Operating Margin (TTM) | 20.62% |
| Diluted EPS (TTM) | -11.85 |
| Quarterly Revenue Growth (YOY) | -19.60% |
| Total Debt/Equity (MRQ) | 745.24% |
| Current Ratio (MRQ) | 1.87 |
| Operating Cash Flow (TTM) | 128.60 M |
| Levered Free Cash Flow (TTM) | 211.51 M |
| Return on Assets (TTM) | 7.16% |
| Return on Equity (TTM) | -104.11% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Chemicals (US) | Bearish | Bearish |
| Specialty Chemicals (Global) | Bearish | Bearish | |
| Stock | Ingevity Corporation | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -4.0 |
| Average | -0.63 |
|
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America. |
|
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Investment Style | Small Value |
| % Held by Insiders | 1.10% |
| % Held by Institutions | 102.48% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Segall Bryant & Hamill, Llc | 31 Dec 2024 | 1,287,281 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 65.00 (BMO Capital, 97.69%) | Buy |
| Median | 48.50 (47.51%) | |
| Low | 32.00 (Wells Fargo, -2.68%) | Hold |
| Average | 48.50 (47.51%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 41.14 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 09 Apr 2025 | 32.00 (-2.68%) | Hold | 33.40 |
| BMO Capital | 26 Feb 2025 | 65.00 (97.69%) | Buy | 48.87 |
| 20 Feb 2025 | 62.00 (88.56%) | Hold | 46.74 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 24 Apr 2025 | Announcement | Ingevity announces dates for first-quarter 2025 earnings release and webcast |
| 20 Mar 2025 | Announcement | Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders |
| 10 Mar 2025 | Announcement | Ingevity announces appointment of David H. Li as president and CEO |
| 25 Feb 2025 | Announcement | Ingevity Highlights Significant Momentum on Actions Underway to Drive Improved Performance and Value Creation |
| 18 Feb 2025 | Announcement | Ingevity reports fourth quarter and full year 2024 financial results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |